Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies
for
Pancreatitis
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT03099850
Recruiting
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
for
Pancreatic Acinar Cell Carcinoma,
Location: Saint Johnsbury VT, Lebanon NH, Commack NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04858334
Phase2, Recruiting
Interested in new pancreatic cancer trials?
Get alerts for new trials in your area by subscribing now
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: Columbus OH, Grand Rapids MI, Houston TX,
Sponsor: Tanabe Pharma America, Inc.
Sex: All
Age: 18+
Code: NCT06943521
Phase1, Phase2, Recruiting
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: Boston MA, New Haven CT, New Brunswick NJ, Baltimore MD,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06385080
Phase1, Phase2, Recruiting
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Boston MA, Saint Johnsbury VT, Lebanon NH, Commack NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06589804
Phase3, Recruiting
PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC
for
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT06239220
Phase2, Recruiting
New
Prospective Case Series Evaluating 6-Month and 12-Month Outcomes After Cryoneurolysis for Chronic Pain
Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies
for
Pancreatic Adenocarcinoma,
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18+
Code: NCT04361708
Phase1, Recruiting
Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma
for
Pancreatic Ductal Adenocarcinoma
Location: Lake Success NY, New York NY, Philadelphia PA,
Sponsor: Gulam Manji
Sex: All
Age: 18+
Code: NCT06048484
Phase2, Recruiting
Safety and Efficacy of Oral Cannabis in Chronic Spine Pain
for
Back Pain, Neck Pain
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 21 - 70+
Code: NCT05052541
Phase3, Recruiting
Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis
for
Chronic Pancreatitis, Chronic Pain
Location: Charleston SC
Sponsor: VA Office of Research and Development
Sex: All
Age: 18 - 70+
Code: NCT05925036
Phase1, Recruiting
An Evaluation of a New Technique Utilizing a Biologic Glue and Tissue Patch to Seal the Cut Edge of the Pancreas Following Removal of the Tail of the Pancreas